Colgate-Palmolive (NYSE:CL - Get Free Report) insider John W. Kooyman sold 3,497 shares of Colgate-Palmolive stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total transaction of $326,864.59. Following the transaction, the insider now owns 3,181 shares in the company, valued at approximately $297,328.07. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
Colgate-Palmolive Stock Performance
Colgate-Palmolive stock opened at $94.09 on Friday. The company has a debt-to-equity ratio of 13.21, a current ratio of 1.06 and a quick ratio of 0.70. The firm has a market capitalization of $77.20 billion, a P/E ratio of 29.78, a price-to-earnings-growth ratio of 3.43 and a beta of 0.40. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $94.40. The company's 50-day moving average is $88.78 and its 200 day moving average is $82.71.
Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The firm had revenue of $5.07 billion for the quarter, compared to the consensus estimate of $4.96 billion. During the same period in the prior year, the business posted $0.73 earnings per share. The company's revenue for the quarter was up 6.2% on a year-over-year basis. Research analysts forecast that Colgate-Palmolive will post 3.52 EPS for the current year.
Colgate-Palmolive Increases Dividend
Look Who Fired the World’s Richest Man
From Banyan Hill Publishing | Ad
This company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S.
And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.
Get the full story here.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be issued a dividend of $0.50 per share. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.48. This represents a $2.00 annualized dividend and a yield of 2.13%. The ex-dividend date is Friday, April 19th. Colgate-Palmolive's dividend payout ratio (DPR) is presently 63.29%.
Institutional Trading of Colgate-Palmolive
A number of hedge funds have recently added to or reduced their stakes in the business. Mitsubishi UFJ Trust & Banking Corp raised its holdings in shares of Colgate-Palmolive by 0.7% in the 1st quarter. Mitsubishi UFJ Trust & Banking Corp now owns 983,122 shares of the company's stock valued at $88,125,000 after purchasing an additional 6,594 shares in the last quarter. Te Ahumairangi Investment Management Ltd grew its position in shares of Colgate-Palmolive by 4.1% in the 1st quarter. Te Ahumairangi Investment Management Ltd now owns 45,117 shares of the company's stock worth $4,063,000 after buying an additional 1,760 shares during the last quarter. First Foundation Advisors raised its stake in shares of Colgate-Palmolive by 37.9% during the 1st quarter. First Foundation Advisors now owns 1,626 shares of the company's stock worth $146,000 after acquiring an additional 447 shares in the last quarter. Mizuho Markets Americas LLC lifted its position in Colgate-Palmolive by 104.3% during the first quarter. Mizuho Markets Americas LLC now owns 126,867 shares of the company's stock valued at $11,424,000 after acquiring an additional 64,773 shares during the last quarter. Finally, M&G Plc acquired a new stake in Colgate-Palmolive in the first quarter valued at approximately $3,812,000. 80.41% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on CL shares. Bank of America boosted their price objective on Colgate-Palmolive from $90.00 to $100.00 and gave the company a "buy" rating in a research note on Monday, April 29th. StockNews.com cut shares of Colgate-Palmolive from a "strong-buy" rating to a "buy" rating in a research note on Tuesday, February 20th. Raymond James upgraded Colgate-Palmolive from a "market perform" rating to an "outperform" rating and set a $91.00 price target for the company in a research note on Monday, January 29th. Wells Fargo & Company boosted their price target on Colgate-Palmolive from $90.00 to $92.00 and gave the stock an "equal weight" rating in a report on Monday, April 29th. Finally, JPMorgan Chase & Co. raised their price objective on Colgate-Palmolive from $88.00 to $90.00 and gave the company an "overweight" rating in a research report on Thursday, January 18th. Three investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $91.44.
Read Our Latest Research Report on Colgate-Palmolive
About Colgate-Palmolive
(
Get Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
